000 | 01155 a2200325 4500 | ||
---|---|---|---|
005 | 20250517085633.0 | ||
264 | 0 | _c20161013 | |
008 | 201610s 0 0 eng d | ||
022 | _a2044-5385 | ||
024 | 7 |
_a10.1038/bcj.2016.20 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLam, K | |
245 | 0 | 0 |
_aLoss of RUNX1 function results in enhanced granulocyte-colony-stimulating factor-mediated mobilization. _h[electronic resource] |
260 |
_bBlood cancer journal _cMar 2016 |
||
300 |
_ae407 p. _bdigital |
||
500 | _aPublication Type: Letter; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aCore Binding Factor Alpha 2 Subunit _xdeficiency |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xpharmacology |
650 | 0 | 4 | _aHematopoietic Stem Cell Mobilization |
650 | 0 | 4 |
_aHematopoietic Stem Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
700 | 1 | _aMuselman, A | |
700 | 1 | _aDu, R | |
700 | 1 | _aYan, M | |
700 | 1 | _aMatsuura, S | |
700 | 1 | _aZhang, D-E | |
773 | 0 |
_tBlood cancer journal _gvol. 6 _gp. e407 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/bcj.2016.20 _zAvailable from publisher's website |
999 |
_c25864413 _d25864413 |